HEG1 , BAP1 , and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusion-Reference-Cited by-同舟云学术

HEG1 , BAP1 , and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusion

Published:2020-05-22 Issue:5 Volume:49 Page:622-632
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagnostic Cytopathology

Author:

Hiroshima Kenzo¹²³^ORCID,Wu Di²,Hamakawa Shinji⁴,Tsuruoka Shingo⁵,Ozaki Daisuke⁶,Orikasa Hideki⁷,Hasegawa Mizue⁸,Koh Eitetsu⁹,Sekine Yasuo⁹,Yonemori Yoko⁶,Nabeshima Kazuki¹⁰,Tsuji Shoutaro¹¹,Miyagi Yohei¹²,Imai Kohzoh¹³

Affiliation:

1. Department of Biochemistry and Genetics Chiba University Graduate School of Medicine Chiba Japan

2. Department of Pathology Tokyo Women's Medical University, Yachiyo Medical Center Yachiyo Japan

3. Department of Medicine Sodegaura Satsukidai Hospital Sodegaura Japan

4. Department of Clinical Laboratory Showa General Hospital Kodaira Japan

5. Department of Pathology Saitama Medical Center, JCHO Saitama Japan

6. Department of Pathology Chiba Rosai Hospital Ichihara Japan

7. Department of Pathology Kawasaki Municipal Hospital Kawasaki Japan

8. Department of Respiratory Medicine Tokyo Women's Medical University, Yachiyo Medical Center Yachiyo Japan

9. Department of Thoracic Surgery Tokyo Women's Medical University, Yachiyo Medical Center Yachiyo Japan

10. Department of Pathology Fukuoka University School of Medicine and Hospital Fukuoka Japan

11. Division of Cancer Therapeutics Kanagawa Cancer Center Research Institute Yokohama Japan

12. Molecular Pathology and Genetics Division Kanagawa Cancer Center Research Institute Yokohama Japan

13. Research Platform Office, The Institute of Medical Science The University of Tokyo Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dc.24475

Reference35 articles.

1. Malignant mesothelioma 1982: Review of 4710 published cases

2. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

3. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

4. BTS statement on malignant mesothelioma in the UK, 2007;British Thoracic Society Standards of Care C;Thorax,2007

5. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal Mesothelioma;Applied Immunohistochemistry & Molecular Morphology;2024-05-28

2. Investigation of HEG1, VISTA (VSIR) and PD-L1 expression levels in malignant mesothelioma by immunohistochemical methods and their relationship with histological subtypes;Biotechnology & Biotechnological Equipment;2024-03-09

3. Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma;Modern Pathology;2024-03

4. Formalin-Fixed Paraffin-Embedded Proteomics of Malignant Mesothelioma and New Candidate Biomarkers Thioredoxin and Superoxide Dismutase 2 for Immunohistochemistry;Laboratory Investigation;2024-02

5. Malignant and borderline mesothelial tumors of the pleura;Practical Pulmonary Pathology;2024